home
about us
delivery platforms
product pipeline
subsidiaries
news and events
contact us
recent news
MicroDose Therapeutx Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV)
industry happenings
